Ivosidenib + Capecitabine + Zanidatamab + Capecitabine + FUTIBATINIB

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Ivosidenib + Capecitabine + Zanidatamab + Capecitabine + FUTIBATINIB
Treatment and conditionWhere it standsTrials
Ivosidenib + Capecitabine + Zanidatamab + Capecitabine + FUTIBATINIB for cholangiocarcinomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1